|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 261, Issue 6 1756-H1762, Copyright © 1991 by American Physiological Society
ARTICLES |
R. R. Russell 3rd and H. Taegtmeyer
Department of Medicine, University of Texas Medical School, Houston 77030.
Acetoacetate, when present as the only fuel for respiration in rat hearts, causes an impairment in contractile function that is reversible with the addition of substrates that can contribute to anaplerosis. To determine the importance of pyruvate carboxylation via NADP(+)-dependent malic enzyme on metabolism and function in hearts oxidizing acetoacetate, isolated working rat hearts were perfused with [1-14C]pyruvate and acetoacetate. While the cardiac power output after 60 min of perfusion in hearts utilizing acetoacetate alone had fallen to 44% of the initial value, the addition of pyruvate resulted in a stable performance with no fall in the work output. When hydroxymalonate, an inhibitor of NADP(+)-dependent malic enzyme and malate dehydrogenase, was added to the two substrates, function at 60 min was similar to the value for hearts oxidizing acetoacetate alone. Measurements of the specific activities of malate, aspartate, and citrate confirm inhibition of both pyruvate carboxylation and malate oxidation. The findings are consistent with a mechanism in which the enrichment of malate by pyruvate improves function by increasing the production of reducing equivalents by the malate dehydrogenase and the isocitrate dehydrogenase reactions increase flux through the span of the tricarboxylic acid cycle from malate to 2-oxoglutarate. The present study demonstrates the physiological importance of anaplerotic pathways in maintaining contractile function in the heart.
This article has been cited by other articles:
![]() |
L. Hue and H. Taegtmeyer The Randle cycle revisited: a new head for an old hat Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E578 - E591. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sorokina, J. M. O'Donnell, R. D. McKinney, K. M. Pound, G. Woldegiorgis, K. F. LaNoue, K. Ballal, H. Taegtmeyer, P. M. Buttrick, and E. D. Lewandowski Recruitment of Compensatory Pathways to Sustain Oxidative Flux With Reduced Carnitine Palmitoyltransferase I Activity Characterizes Inefficiency in Energy Metabolism in Hypertrophied Hearts Circulation, April 17, 2007; 115(15): 2033 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Korge and J. N. Weiss Redox regulation of endogenous substrate oxidation by cardiac mitochondria Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1436 - H1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Okere, T. A. McElfresh, D. Z. Brunengraber, W. Martini, J. P. Sterk, H. Huang, M. P. Chandler, H. Brunengraber, and W. C. Stanley Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemia-reperfusion J Appl Physiol, January 1, 2006; 100(1): 76 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Dawson, D. J. Baker, P. L. Greenhaff, and M. J. Gibala An acute decrease in TCA cycle intermediates does not affect aerobic energy delivery in contracting rat skeletal muscle J. Physiol., June 1, 2005; 565(2): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khairallah, F. Labarthe, B. Bouchard, G. Danialou, B. J. Petrof, and C. Des Rosiers Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1461 - H1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vincent, B. Bouchard, M. Khairallah, and C. Des Rosiers Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H257 - H266. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg., February 1, 2003; 75(2): S721 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Lazar The Insulin Cardioplegia Trial J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 842 - 844. [Full Text] [PDF] |
||||
![]() |
G. Hasenfuss, L. S. Maier, H.-P. Hermann, C. LUers, M. HUnlich, O. Zeitz, P. M.L. Janssen, and B. Pieske Influence of Pyruvate on Contractile Performance and Ca2+ Cycling in Isolated Failing Human Myocardium Circulation, January 15, 2002; 105(2): 194 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Panchal, B. Comte, H. Huang, B. Dudar, B. Roth, M. Chandler, C. Des Rosiers, H. Brunengraber, and W. C. Stanley Acute hibernation decreases myocardial pyruvate carboxylation and citrate release Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1613 - H1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Hegge, J. H. Southard, and R. A. Haworth Preservation of metabolic reserves and function after storage of myocytes in hypothermic UW solution Am J Physiol Cell Physiol, September 1, 2001; 281(3): C758 - C772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Panchal, B. Comte, H. Huang, T. Kerwin, A. Darvish, C. D. Rosiers, H. Brunengraber, and W. C. Stanley Partitioning of pyruvate between oxidation and anaplerosis in swine hearts Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2390 - H2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Lazar, S. Chipkin, G. Philippides, Y. Bao, and C. Apstein Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations Ann. Thorac. Surg., July 1, 2000; 70(1): 145 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Mallet Pyruvate: Metabolic Protector of Cardiac Performance Experimental Biology and Medicine, February 1, 2000; 223(2): 136 - 148. [Abstract] [Full Text] |
||||
![]() |
C. Depre, J.-L. J. Vanoverschelde, and H. Taegtmeyer Glucose for the Heart Circulation, February 2, 1999; 99(4): 578 - 588. [Full Text] [PDF] |
||||
![]() |
M. J. Gibala, D. A. MacLean, T. E. Graham, and B. Saltin Tricarboxylic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E235 - E242. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Cohen and R. N. Bergman Improved estimation of anaplerosis in heart using 13C NMR Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1228 - E1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Comte, G. Vincent, B. Bouchard, and C. D. Rosiers Probing the Origin of Acetyl-CoA and Oxaloacetate Entering the Citric Acid Cycle from the 13C Labeling of Citrate Released by Perfused Rat Hearts J. Biol. Chem., October 17, 1997; 272(42): 26117 - 26124. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Comte, G. Vincent, B. Bouchard, M. Jette, S. Cordeau, and C. D. Rosiers A 13C Mass Isotopomer Study of Anaplerotic Pyruvate Carboxylation in Perfused Rat Hearts J. Biol. Chem., October 17, 1997; 272(42): 26125 - 26131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |